Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 132, Issue 1, Pages 215-223
Publisher
Springer Nature
Online
2011-12-03
DOI
10.1007/s10549-011-1889-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- XeNA: Capecitabine Plus Docetaxel, With or Without Trastuzumab, as Preoperative Therapy for Early Breast Cancer
- (2012) Stefan Glück et al. International Journal of Medical Sciences
- Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy
- (2011) Christophe Glorieux et al. BIOCHEMICAL PHARMACOLOGY
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer
- (2011) Alberto J. Montero et al. DRUGS
- Selective targeting of breast cancer cells through ROS-mediated mechanisms potentiates the lethality of paclitaxel by a novel diterpene, gelomulide K
- (2011) Juan-Cheng Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer
- (2011) Kenneth D. Tew et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
- (2010) M. E. Straver et al. ANNALS OF SURGICAL ONCOLOGY
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma
- (2010) Christopher M. Cabello et al. FREE RADICAL RESEARCH
- Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma
- (2010) Steven E. Finkelstein et al. JOURNAL OF IMMUNOTHERAPY
- Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
- (2009) Georg T. Wondrak ANTIOXIDANTS & REDOX SIGNALING
- IL4Rα + Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
- (2009) Susanna Mandruzzato et al. JOURNAL OF IMMUNOLOGY
- Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications
- (2008) Margret S. Rodrigues et al. ANTIOXIDANTS & REDOX SIGNALING
- Redox Regulation of Cell Survival
- (2008) Dunyaporn Trachootham et al. ANTIOXIDANTS & REDOX SIGNALING
- Pharmacology of a mimetic of glutathione disulfide, NOV-002
- (2008) Danyelle M. Townsend et al. BIOMEDICINE & PHARMACOTHERAPY
- A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk
- (2008) Chunyan He et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NOV-002, a Glutathione Disulfide Mimetic, as a Modulator of Cellular Redox Balance
- (2008) D. M. Townsend et al. CANCER RESEARCH
- Lymphopenia Associated with Adjuvant Anthracycline/Taxane Regimens
- (2008) Sara M. Tolaney et al. Clinical Breast Cancer
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- NOV-002, a mimetic of glutathione disulfide
- (2008) Danyelle M Townsend et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Proper inference from Simon's two‐stage designs
- (2007) Tatsuki Koyama et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now